奥翔药业
(603229)
| 流通市值：67.17亿 | | | 总市值：67.17亿 |
| 流通股本：8.30亿 | | | 总股本：8.30亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,104,801,644.13 | 1,096,287,944.72 | 1,025,415,953.27 | 989,376,385.99 |
| 应收票据及应收账款 | 326,512,713.44 | 192,215,593.45 | 297,980,423.09 | 306,593,182.66 |
| 其中：应收票据 | - | - | 4,243,761.81 | - |
| 应收账款 | 326,512,713.44 | 192,215,593.45 | 293,736,661.28 | 306,593,182.66 |
| 应收款项融资 | 4,591,814.9 | 4,363,963.45 | - | - |
| 预付款项 | 3,340,338.62 | 1,210,873.16 | 7,836,996.32 | 6,482,429.57 |
| 其他应收款合计 | 2,570,103.09 | 1,633,979.15 | 1,688,235.09 | 1,850,763.05 |
| 存货 | 384,355,661.51 | 400,949,911.46 | 363,363,381.43 | 361,866,083.92 |
| 其他流动资产 | 5,287,238.42 | 10,264,712.4 | 40,179,372.31 | 38,150,504.36 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,836,403,912.68 | 1,709,169,547.87 | 1,736,464,361.51 | 1,704,319,349.55 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 500,000 | 500,000 | 500,000 | 500,000 |
| 其他非流动金融资产 | 72,060,765.18 | 72,060,765.18 | 69,116,092.68 | 69,116,092.68 |
| 固定资产 | 547,712,026.85 | 543,215,472.7 | 486,358,490.41 | 499,540,583.6 |
| 在建工程 | 503,220,850.16 | 495,664,029.29 | 561,949,711.58 | 541,506,132.85 |
| 使用权资产 | 1,647,026.06 | 1,946,756.57 | 2,146,576.91 | 2,446,307.42 |
| 无形资产 | 154,476,804.1 | 155,392,216.42 | 147,914,198.71 | 148,865,231.08 |
| 递延所得税资产 | - | 455,987.91 | - | - |
| 其他非流动资产 | 4,537,327.58 | 3,985,274.45 | 13,174,489.85 | 14,339,045.22 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,284,154,799.93 | 1,273,220,502.52 | 1,281,159,560.14 | 1,276,313,392.85 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,120,558,712.61 | 2,982,390,050.39 | 3,017,623,921.65 | 2,980,632,742.4 |
| 流动负债: | | | | |
| 短期借款 | 290,088,710.7 | 270,309,905.42 | 300,328,012.22 | 200,255,555.56 |
| 交易性金融负债 | - | - | 67,095.26 | 597,590.59 |
| 应付票据及应付账款 | 370,782,794.97 | 351,635,398.76 | 346,696,967.59 | 381,331,112.26 |
| 其中：应付票据 | 156,687,145.07 | 143,554,697.59 | 120,975,330.76 | 131,166,118.02 |
| 应付账款 | 214,095,649.9 | 208,080,701.17 | 225,721,636.83 | 250,164,994.24 |
| 合同负债 | 10,120,279.04 | 908,529.9 | 2,665,757.74 | 5,096,640.65 |
| 应付职工薪酬 | 22,672,080.11 | 41,370,089.44 | 26,731,188.64 | 22,397,888.08 |
| 应交税费 | 17,716,909.98 | 8,301,562.19 | 7,732,983.44 | 10,933,650.34 |
| 其他应付款合计 | 2,069,216.1 | 937,837.96 | 1,052,822.34 | 1,032,351 |
| 一年内到期的非流动负债 | 871,483.26 | 1,036,241.73 | 871,483.26 | 871,483.26 |
| 其他流动负债 | 108,727.63 | 26,150.36 | 125,231.99 | 132,331.14 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 714,430,201.79 | 674,525,715.76 | 686,271,542.48 | 622,648,602.88 |
| 非流动负债: | | | | |
| 租赁负债 | 1,022,684.05 | 1,082,479.96 | 1,877,728.25 | 2,097,529.53 |
| 递延收益 | 33,249,137.32 | 34,890,651.96 | 35,206,574.87 | 33,682,524.86 |
| 递延所得税负债 | 83,109.96 | - | 204,431.74 | 779,519.54 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 34,354,931.33 | 35,973,131.92 | 37,288,734.86 | 36,559,573.93 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 748,785,133.12 | 710,498,847.68 | 723,560,277.34 | 659,208,176.81 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 830,297,145 | 830,297,145 | 830,297,145 | 593,069,389 |
| 资本公积 | 440,225,349.82 | 440,225,349.82 | 440,225,349.82 | 677,453,105.82 |
| 减:库存股 | 2,133,186.2 | - | - | - |
| 其他综合收益 | -162,245.1 | -832,491.63 | -854,706.47 | -846,456.95 |
| 盈余公积 | 129,879,465.56 | 129,879,465.56 | 104,758,817.79 | 104,758,817.79 |
| 未分配利润 | 973,667,050.41 | 872,321,733.96 | 919,637,038.17 | 946,989,709.93 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,371,773,579.49 | 2,271,891,202.71 | 2,294,063,644.31 | 2,321,424,565.59 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,371,773,579.49 | 2,271,891,202.71 | 2,294,063,644.31 | 2,321,424,565.59 |
| 负债和股东权益合计 | 3,120,558,712.61 | 2,982,390,050.39 | 3,017,623,921.65 | 2,980,632,742.4 |
| 公告日期 | 2025-04-30 | 2025-04-30 | 2024-10-30 | 2024-08-24 |
| 审计意见(境内) | | 标准无保留意见 | | |